Product NDC: | 55505-137 |
Proprietary Name: | Safetussin |
Non Proprietary Name: | Dextromethorpan Hydrobromide Guaifenesin |
Active Ingredient(s): | 30; 200 mg/10mL; mg/10mL & nbsp; Dextromethorpan Hydrobromide Guaifenesin |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55505-137 |
Labeler Name: | Kramer Laboratories |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20101209 |
Package NDC: | 55505-137-20 |
Package Description: | 120 mL in 1 BOTTLE, PLASTIC (55505-137-20) |
NDC Code | 55505-137-20 |
Proprietary Name | Safetussin |
Package Description | 120 mL in 1 BOTTLE, PLASTIC (55505-137-20) |
Product NDC | 55505-137 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Dextromethorpan Hydrobromide Guaifenesin |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20101209 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Kramer Laboratories |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Strength Number | 30; 200 |
Strength Unit | mg/10mL; mg/10mL |
Pharmaceutical Classes |